Qube Research & Technologies (QRT)
TNGX icon

Qube Research & Technologies (QRT)’s Tango Therapeutics TNGX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-318,676
Closed -$2.82M – 4133
2025
Q4 		$2.82M Buy
+318,676
New +$2.75M ﹤0.01% 2086

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TNGX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 318,676 shares — an estimated $2.82M sold.

Qube Research & Technologies (QRT) first reported a position in TNGX in Q4 2025 and held it in 1 quarter. The position peaked at $2.82M in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 318,676 Tango Therapeutics shares in Q1 2026, an estimated $2.82M.
  • Qube Research & Technologies (QRT) first reported a position in Tango Therapeutics in Q4 2025 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Tango Therapeutics position peaked at $2.82M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.